Search results for "new drug"

Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms toxic plaques between brain cells,...
From Saliva to Gut: How Human Anatomy Differs from Dogs and Lions

From Saliva to Gut: How Human Anatomy Differs from Dogs and Lions

As discussed in last week’s column(*), the structure of the human mouth—including the jaw joint and teeth—more closely resembles that of herbivores...
Mixing Meds and Supplements: Why Red Ginseng Demands Caution for Diabetics

Mixing Meds and Supplements: Why Red Ginseng Demands Caution for Diabetics

Dietary supplements concentrate health-promoting ingredients into convenient, everyday forms.
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax & Kael announced on June 10 that a study detailing the therapeutic mechanism of its Alzheimer’s disease drug...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
South Korean Researchers Discover Compound That Destroys Chemo-Resistant Liver Cancer Cells

South Korean Researchers Discover Compound That Destroys Chemo-Resistant Liver Cancer Cells

Cancer cells that no longer respond to chemotherapy present one of the most formidable challenges in oncology.
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
South Korean Biotechs Race to Conquer the Untapped Global MASH Market

South Korean Biotechs Race to Conquer the Untapped Global MASH Market

Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.